Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients

Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients

Background: Research over the past decade has focused on the role of Klotho as a cardio protective agent that prevents the effects of aging on the heart and reduces the burden of cardiovascular disease CVD. The role of the interaction between fibroblast growth factor 23-(FGF-23)/Klotho in Klotho-med...

Full description

Bibliographic Details
Main Authors: Ana Paula Silva, Filipa Mendes, Eduarda Carias, Rui Baptista Gonçalves, André Fragoso, Carolina Dias, Nelson Tavares, Hugo Mendonça Café, Nélio Santos, Fátima Rato, Pedro Leão Neves, Edgar Almeida
Format: Article
Language:English
Published: MDPI AG 2019-03-01
Series:International Journal of Molecular Sciences
Subjects:
klotho
FGF-23
CKD
CVD
LVMI
Online Access:https://www.mdpi.com/1422-0067/20/7/1536

Internet

https://www.mdpi.com/1422-0067/20/7/1536

Similar Items